Medical Weight Loss for Glen Burnie, Maryland Residents

Glen Burnie, Maryland residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Glen Burnie through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Glen Burnie: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Maryland. Results vary. Doctor review just $119 (medication separate).

Why Glen Burnie Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A Glen Burnie patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in Maryland gets.

From our Costa Mesa, California practice, we provide Glen Burnie with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

Whether you are near downtown Glen Burnie or somewhere quieter in Maryland, the same doctor-supervised plan runs over telehealth, with our only physical location remaining in Costa Mesa, California. We care for patients throughout Glen Burnie and the greater Anne Arundel County area south of Baltimore. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in Maryland.

Because your care happens by telehealth, there is no waitlist to clear and most Glen Burnie patients can have their physician visit scheduled within the same week. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. New Hope Weight Loss serves patients throughout Maryland entirely by telehealth from our Costa Mesa, California clinic, delivering physician-supervised GLP-1 programs without an office visit.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Glen Burnie telehealth patients.

How Telehealth Works for Glen Burnie

No waiting rooms, no commute across Glen Burnie traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Glen Burnie home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Glen Burnie

I live in Glen Burnie. Is the nearest New Hope Weight Loss office close by?

The nearest office is in Costa Mesa, California, which is our only physical site. That said, you do not have to be near it. We treat Glen Burnie, Maryland patients by telehealth, and a video consult with Dr. Anjmun Sharma confirms whether you are a candidate for compounded semaglutide or tirzepatide.

Will I ever need to show up in person if I am in Glen Burnie?

No in-person visits are needed for Glen Burnie residents. The entire program is telehealth, from your first consult to refills and check-ins. When you qualify, your medication ships to Glen Burnie in cold-pack packaging designed to maintain the proper temperature throughout shipping.

What are the prices for Glen Burnie residents?

A physician review costs $119. Compounded semaglutide is priced from $166 per month or $499 for a 90-day course, and tirzepatide from $233 per month. Medication is charged on its own. Payment through HSA, FSA, Klarna, or Affirm is accepted, and we never add a distance surcharge for Glen Burnie.

What areas of Glen Burnie do you serve?

We serve patients from across Glen Burnie by telehealth, including Glen Burnie and the greater Anne Arundel County area south of Baltimore.

What support is there for side effects for Glen Burnie patients?

Dr. Sharma starts Glen Burnie patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.

Glen Burnie Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Glen Burnie, Maryland by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.